DILIGENT PHARMA

Serial Number 98440018
Registration 7814250
700

Registration Progress

Application Filed
Mar 8, 2024
Under Examination
Approved for Publication
Apr 15, 2025
Published for Opposition
Apr 15, 2025
Registered
Jun 3, 2025

Trademark Image

DILIGENT PHARMA

Basic Information

Serial Number
98440018
Registration Number
7814250
Filing Date
March 8, 2024
Registration Date
June 3, 2025
Published for Opposition
April 15, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 3, 2025
Registration
Registered
Classes
035 042

Rights Holder

Diligent Pharma, Inc.

03
Address
179 Nassau St., Suite 3A
Princeton, NJ 08542

Ownership History

Diligent Pharma, Inc.

Original Applicant
03
Princeton, NJ

Diligent Pharma, Inc.

Owner at Publication
03
Princeton, NJ

Diligent Pharma, Inc.

Original Registrant
03
Princeton, NJ

Legal Representation

Attorney
Harris A. Wolin

USPTO Deadlines

Next Deadline
2036 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-03)
Due Date
June 03, 2031
Grace Period Ends
December 03, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Jun 3, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 3, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 15, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 15, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 9, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 19, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 18, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 18, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 18, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 18, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 18, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Mar 18, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 18, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 21, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 21, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 21, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 24, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 24, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 24, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 20, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 22, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 11, 2024 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Mar 8, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Technical consulting the field of assisting with the selection of technical service providers for clinical trials; Technical consulting in the field of clinical trial vendor selection; Technical consulting in the field of selection and management of technical service provider vendors for clinical trials; Technical consulting in the field of clinical trial third party vendor selection and management
First Use Anywhere: 20240100
First Use in Commerce: 20240100
Class 042
Technical consulting in the field of pharmaceutical studies; Providing online non-downloadable software for assisting third parties in selecting technical service providers to manage clinical trials for the testing of drugs, biologics, and medical devices; Providing online non-downloadable software for clinical trial vendor selection and management
First Use Anywhere: 20240100
First Use in Commerce: 20240100

Classification

International Classes
035 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
PHARMA